Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Xphyto Therapeutics Corp (XPHYF)

Xphyto Therapeutics Corp (XPHYF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 85,231
  • Shares Outstanding, K 73,003
  • Annual Sales, $ 260 K
  • Annual Income, $ -12,610 K
  • 60-Month Beta N/A
  • Price/Sales 334.40
  • Price/Cash Flow N/A
  • Price/Book 19.47
Trade XPHYF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.21
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/27/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0800 +7.18%
on 08/27/21
1.5000 -22.83%
on 08/18/21
-0.3175 (-21.53%)
since 08/16/21
3-Month
1.0000 +15.75%
on 07/21/21
1.7200 -32.70%
on 06/17/21
-0.5425 (-31.91%)
since 06/16/21
52-Week
1.0000 +15.75%
on 07/21/21
3.1000 -62.66%
on 01/28/21
-1.0217 (-46.88%)
since 09/16/20

Most Recent Stories

More News
InvestorNewsBreaks XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Proprietary COVID-19 PCR Test COVID-ID Lab Launch Deemed a Success

(MENAFN - Investor Brand Network) XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) , a bioscience accelerator at the leading-edge of the life science industry, announced that the market launch...

XPHY.CN : 1.500 (unch)
XPHYF : 1.1575 (-0.86%)
XPhyto Reports Successful Market Launch and Growing Demand for its 25-minute COVID-19 PCR Test COVID-ID Lab

VANCOUVER, BC and FRANKFURT, GERMANY / ACCESSWIRE / September 8, 2021 / (CSE:XPHY) (OTCQB:XPHYF) (FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the successful market launch of its 25-minute...

XPHY.CN : 1.500 (unch)
XPHYF : 1.1575 (-0.86%)
XPhyto Launches First Commercial Biosensor for Oral Disease

Biosensor test dissolves on the tongue and turns bitter indicating the presence of oral inflammation after five minutesEasy and simple at-home self-checks improve oral health and indicate inflammation...

XPHY.CN : 1.500 (unch)
XPHYF : 1.1575 (-0.86%)
XPhyto's Acquisition Target, 3a-Diagnostics, Reports Breakthrough Identification of COVID-19 Biosensor Candidates

First saliva activated biosensor molecules identified to diagnose COVID-19 infection using XPhyto's oral dissolvable delivery platform Biosensor candidates are ready for optimization and performance assessment...

XPHY.CN : 1.500 (unch)
XPHYF : 1.1575 (-0.86%)
XPhyto Signs Transformative Acquisition Agreement With 3a-Diagnostics, to Enter Hi-Tech Biosensor Market and Expand Its Diagnostic Product Portfolio

The acquisition creates significant commercial development and manufacturing opportunities for XPhyto as well as cost synergies and improved margins on its diagnostic products.The acquisition secures XPhyto...

XPHYF : 1.1575 (-0.86%)
XPHY.CN : 1.500 (unch)
XPhyto Announces Advertising Agreement with Agora Internet Relations Corp.

VANCOUVER, BC / ACCESSWIRE / July 2, 2021 / (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") announces that pursuant to its advertising agreement with AGORA Internet Relations Corp. ("AGORA")...

XPHY.CN : 1.500 (unch)
XPHYF : 1.1575 (-0.86%)
XPhyto Supplies 10 Test Centers in Berlin with 25-minute COVID-19 PCR Test

XPhyto signs master supply agreement with operator of 10 COVID-19 test centersThe test will be offered to customers as a rapid PCR test with sample processing on siteCommercial operations expected to commence...

XPHY.CN : 1.500 (unch)
XPHYF : 1.1575 (-0.86%)
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Hugh Rogers, CEO of XPhyto Therapeutics Corp.

via InvestorWire -- InvestorBrandNetwork ("IBN"), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of an...

XPHY.CN : 1.500 (unch)
XPHYF : 1.1575 (-0.86%)
XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Latest Progress Report on Mescaline Program for Psychedelic Therapies

via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient...

XPHY.CN : 1.500 (unch)
XPHYF : 1.1575 (-0.86%)
XPhyto Provides Progress Report on Mescaline Program for Psychedelic Therapies

Research and development lab set up, preliminary mescaline synthesis completeModified synthesis process developed, mescaline batches manufacturedDevelopment of analytical methods and validation, GMP standard...

XPHY.CN : 1.500 (unch)
XPHYF : 1.1575 (-0.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 1.2352
2nd Resistance Point 1.2046
1st Resistance Point 1.1811
Last Price 1.1575
1st Support Level 1.1270
2nd Support Level 1.0964
3rd Support Level 1.0729

See More

52-Week High 3.1000
Fibonacci 61.8% 2.2978
Fibonacci 50% 2.0500
Fibonacci 38.2% 1.8022
Last Price 1.1575
52-Week Low 1.0000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar